Joseph Sulzbach

Joseph Sulzbach is an associate in the Corporate practice group in the firm’s New York office.

Mr. Sulzbach’s practice focuses on domestic and cross-border corporate transactions, principally in connection with public and private mergers and acquisitions, joint ventures and corporate governance matters. He represents a broad array of U.S.-based and international clients, ranging from global corporations to closely held companies.

Mr. Sulzbach received his J.D. magna cum laude from Hofstra University School of Law, where he was an associate editor for the Hofstra Law Review. While in law school, Mr. Sulzbach served as a legal extern at the Financial Industry Regulatory Authority, the U.S. Securities and Exchange Commission, and the New York State Department of Financial Services. He received his B.A. from Gettysburg College.

Select examples of Mr. Sulzbach’s experience include the following:

• Represented Rao’s Specialty Foods, Inc. in its sale to Sovos Brands, an affiliate of funds managed by Advent International.
• Represented JERA in the acquisition of a 43% stake in Cricket Valley Energy Center, the developer of a 1,000MW natural gas-fired power plant located in Dover, New York.
• Represented Renesas Electronics in its $3.2 billion acquisition of Intersil Corporation.
• Represented Ducera Securities as financial advisor to Monsanto Company in its $66 billion sale to Bayer AG.
• Represented DaVita HealthCare Partners in its acquisition of Renal Ventures Limited.
• Represented Inovalon Holdings, Inc. in its acquisition of Creehan Holding Co., Inc.
• Represented Inovalon Holdings, Inc. in its acquisition of Avalere Health, Inc.
• Represented Global Logistic Properties in its acquisition of a $4.55 billion U.S. logistics portfolio from Industrial Income Trust.
• Represented JLB Group, LLC in its acquisition of Sneakz, LLC.
• Represented Futamura Chemical Co., Ltd. in its acquisition of the cellulose business of Innovia Films.
• Represented Kirin Holdings Company, Limited in its acquisition of approximately 24.5% of the capital stock of The Brooklyn Brewery Corporation.